US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist
  • 12.020
  • -0.550-4.38%
Close Dec 13 16:00 ET
  • 12.020
  • 0.0000.00%
Post 20:01 ET
1.28BMarket Cap-4.40P/E (TTM)

About Rocket Pharmaceuticals Company

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.

Company Profile

SymbolRCKT
Company NameRocket Pharmaceuticals
Listing DateFeb 18, 2015
Issue Price6.00
Founded1999
CEODr. Gaurav Shah, M.D.
MarketNASDAQ
Employees268
Fiscal Year Ends12-31
Address9 Cedarbrook Drive
CityCranbury
ProvinceNew Jersey
CountryUnited States of America
Zip Code08512
Phone1-609-659-8001

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Gaurav Shah, M.D.
  • Director and Chief Executive Officer
  • 8.01M
  • Raj Prabhakar
  • Chief Business Officer and Senior Vice President
  • --
  • Martin Wilson, J.D.
  • Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
  • --
  • Mayo Pujols
  • Chief Technical Officer and Executive Vice President
  • 4.38M
  • Aaron Ondrey
  • Chief Financial Officer
  • --
  • Dr. Kinnari Patel, M.B.A.,Pharm.D.
  • President, Chief Operating Officer and Head of R&D
  • 4.85M
  • Jonathan Schwartz, M.D.
  • Chief Medical Officer and Chief Gene Therapy Officer
  • 3.16M
  • Mark White
  • General Manager, Commercial Affairs
  • --
  • John Militello, C.P.A.
  • Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
  • 1.53M
  • Dr. Roderick Wong, M.D.
  • Chairman of the Board
  • 409.99K
  • Dr. Mikael Dolsten, M.D.
  • Director
  • --
  • Dr. Naveen Yalamanchi, M.D.
  • Independent Director
  • 417.49K
  • Dr. Elisabeth Bjork, M.D.,PhD
  • Independent Director
  • 409.99K
  • David P. Southwell
  • Independent Director
  • 399.99K
  • Dr. Gotham Makker, M.D.
  • Independent Director
  • 399.99K
  • Dr. Fady Ibraham Malik, M.D.,PhD
  • Independent Director
  • 399.99K
  • Robert Keith Woods
  • Independent Director
  • 568.70K
  • Pedro P. Granadillo
  • Independent Director
  • 429.98K
  • Carsten Boess
  • Independent Director
  • 427.49K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.